Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02351037
Title A Multicenter Open-Label Phase 2a Study of Ibrutinib With or Without Cytarabine in Subjects With Acute Myeloid Leukemia
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Pharmacyclics
Indications

acute myeloid leukemia

Therapies

Ibrutinib

Cytarabine

Age Groups: adult
Covered Countries USA


No variant requirements are available.